Latest News

New drugs offer hope for migraine prevention

Two new studies may offer hope for people with migraines. Both studies involve drugs that are aimed at preventing migraine attacks from occurring, rather than stopping the attacks once they have started. These studies are the first to test monoclonal antibodies for the prevention of migraine, and both are directed against a relatively new target in migraine prevention, the calcitonin gene-related peptide, or CGRP. CGRP has been thought to be important in migraine, but never have drugs been developed to specifically target the protein.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Depression, personality disorders drive psych patients to euthanasia

  • Seniors get mental health drugs at twice the rate of other adults, see psychiatrists less

  • Every country in the world can afford to support its smokers to stop

  • Depressive ruminations and the idling brain

  • Blood test predicts prognosis for traumatic brain injuries

  • Early prosocial behavior good predictor of kids' future

  • Science educators analyze genetics content of Next Generation Science Standards

  • Study of 'senior citizen' marine snails uncovered how nerve cells fail during learning

  • Targeted therapy shows effectiveness against a subtype of the brain tumor medulloblastoma

  • Naturally occurring protein fragment found in the brain inhibits key enzyme implicated in Alzheimer's disease

  •